4D MOLECULAR THERAPEUTICS IN's ticker is FDMT and the CUSIP is 35104E100. A total of 94 filers reported holding 4D MOLECULAR THERAPEUTICS IN in Q1 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,053,171 | -42.4% | 161,286 | -18.2% | 0.01% | -40.0% |
| Q2 2023 | $3,562,591 | +53.8% | 197,155 | +46.3% | 0.02% | +25.0% |
| Q1 2023 | $2,317,006 | +117.6% | 134,788 | +181.2% | 0.02% | +77.8% |
| Q4 2022 | $1,064,592 | -1.9% | 47,933 | -33.2% | 0.01% | +50.0% |
| Q1 2022 | $1,085,000 | -34.7% | 71,774 | -5.2% | 0.01% | -33.3% |
| Q4 2021 | $1,661,000 | – | 75,713 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 1,566,895 | $23,691,000 | 5.12% |
| Aquilo Capital Management, LLC | 1,755,506 | $26,543,000 | 3.90% |
| Deep Track Capital, LP | 2,448,200 | $37,017,000 | 2.37% |
| BVF INC/IL | 2,664,521 | $40,288,000 | 1.61% |
| Opaleye Management Inc. | 325,000 | $4,914,000 | 1.53% |
| Perigon Wealth Management, LLC | 557,475 | $8,429,000 | 0.60% |
| Eagle Health Investments LP | 132,090 | $1,997,000 | 0.49% |
| Casdin Capital, LLC | 555,455 | $8,398,000 | 0.38% |
| VIKING GLOBAL INVESTORS LP | 3,937,914 | $59,541,000 | 0.24% |
| ArrowMark Colorado Holdings LLC | 1,145,585 | $17,321,000 | 0.15% |